Testing effectiveness (Phase 2)Study completedNCT00002715What this trial is testingCombination Chemotherapy in Treating Patients With Advanced Hodgkin's LymphomaWho this might be right forLymphoma Stanford University 50
Large-scale testing (Phase 3)Study completedNCT00003650What this trial is testingCombination Chemotherapy in Treating Children With Non-Hodgkin's LymphomaWho this might be right forLymphoma UNICANCER 179
Early research (Phase 1)Looking for participantsNCT05794958What this trial is testingEvaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-CelWho this might be right forNon-Hodgkin LymphomaLarge B-cell Lymphoma Stanford University 20
Large-scale testing (Phase 3)Ended earlyNCT00060385What this trial is testingCombination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 3
Testing effectiveness (Phase 2)UnknownNCT04378647What this trial is testingBREntuximab Vedotin in SEcond LIne Therapy BEfore TransplantWho this might be right forHodgkin Lymphoma, Adult Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 150
Early research (Phase 1)Study completedNCT00569985What this trial is testingGene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related LymphomaWho this might be right forLymphoma City of Hope Medical Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417What this trial is testingBusulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWho this might be right forHematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more M.D. Anderson Cancer Center 204
Post-approval studies (Phase 4)Study completedNCT00162955What this trial is testingPrevention of CHOP-induced Chronic CardiotoxicityWho this might be right forNon-Hodgkin's Lymphoma Osaka City University 150
Early research (Phase 1)Ended earlyNCT03778073What this trial is testingStudy of Cosibelimab in Subjects With Relapsed or Refractory LymphomaWho this might be right forB-cell Non Hodgkin LymphomaRichter's Transformation TG Therapeutics, Inc. 18
Testing effectiveness (Phase 2)UnknownNCT02229682What this trial is testingMild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX ChemotherapyWho this might be right forLymphoma,Non-Hodgkin Lymphoma,Extranodal NK/T-cell Lymphoma,Nasal-type, Sun Yat-sen University 40
Early research (Phase 1)Looking for participantsNCT06879340What this trial is testingEvaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell MalignanciesWho this might be right forB-Cell Non-Hodgkin LymphomaB-cell Acute Lymphoblastic Leukemia University of Kansas Medical Center 54
Testing effectiveness (Phase 2)UnknownNCT02315118What this trial is testingPilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell MalignanciesWho this might be right forB-Cell Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma National University Hospital, Singapore 18
Early research (Phase 1)Ended earlyNCT02875223What this trial is testingA Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's LymphomasWho this might be right forLymphoma, Non-HodgkinNeoplasms Celgene 75
Early research (Phase 1)Study completedNCT00182650What this trial is testingCellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma City of Hope Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT00521560What this trial is testingZevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin LymphomasWho this might be right forPrimary Non-Hodgkin-LymphomaRefractory Non-Hodgkin-LymphomaCD20+ Aggressive Non-Hodgkin's Lymphoma Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 28
Early research (Phase 1)Study completedNCT02950220What this trial is testingPembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+16 more Kami Maddocks 2
Testing effectiveness (Phase 2)Study completedNCT01393717What this trial is testingBrentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin LymphomaWho this might be right forRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma City of Hope Medical Center 57
Early research (Phase 1)Study completedNCT02651662What this trial is testingLearn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell MalignanciesWho this might be right forRelapsed/Refractory Aggressive B-Cell Lymphoma Regeneron Pharmaceuticals 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT04024696What this trial is testingA Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese PatientsWho this might be right forNon Hodgkin Lymphoma Xynomic Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT00006246What this trial is testingBusulfan in Treating Children and Adolescents With Refractory CNS CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more Pediatric Brain Tumor Consortium 28